Does endoscopic mucosal resection for large colorectal polyps allow ambulatory management?

Area of Science:

• Gastroenterology
• Endoscopy
• Colorectal Surgery

Background:

• Endoscopic mucosal resection (EMR) is a key treatment for large adenomas and confined neoplasia.
• Delayed hemorrhage is the most common complication following EMR.
• Hemoclips are an effective option for managing post-EMR bleeding.

Purpose of the Study:

• To evaluate the feasibility and safety of ambulatory management for large colorectal lesions treated with EMR.
• To assess the impact of hemoclip usage on complication rates in ambulatory EMR.

Main Methods:

• Prospective study of colorectal polyps ≥20 mm treated with EMR from 2007 to 2011.
• Comparison of EMR outcomes between a reference period and subsequent periods with increasing ambulatory management.
• Exclusion of patients on anticoagulation drugs.

Main Results:

• Ambulatory EMR rates increased significantly over the study periods, reaching 88.2%.
• The use of at least one hemoclip per centimeter of polyp size increased from 10.7% to 76%.
• Complication rates remained stable, with no delayed bleeding in patients receiving adequate hemoclip application.

Conclusions:

• Ambulatory EMR for large colorectal lesions (≥20 mm) is a viable option due to low complication rates.
• Applying one hemoclip per centimeter of EMR site may prevent delayed hemorrhage in select patients.
• Further research could explore ambulatory EMR in broader patient populations.